Global Genetic Engineering Drug Market Growth 2023-2029

Global Genetic Engineering Drug Market Growth 2023-2029

Genetic Engineering Drug is also called Genetic Engineering or Genetic manipulation, and is the direct manipulation of an organism's genes using the Drug required in biotechnology.

LPI (LP Information)' newest research report, the “Genetic Engineering Drug Industry Forecast” looks at past sales and reviews total world Genetic Engineering Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Genetic Engineering Drug sales for 2023 through 2029. With Genetic Engineering Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genetic Engineering Drug industry.

This Insight Report provides a comprehensive analysis of the global Genetic Engineering Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genetic Engineering Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Genetic Engineering Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genetic Engineering Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genetic Engineering Drug.

The global Genetic Engineering Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Genetic Engineering Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Genetic Engineering Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Genetic Engineering Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Genetic Engineering Drug players cover Shanghai Lansheng Guojian Pharmaceutical, Biotech Pharmaceutical, Anhui Anke Biotechnology, GeneScience Pharmaceuticals, Beijing SL Pharmaceutical, Jiangsu Sihuan Bioengineering, Shenzhen Neptunus Interlong Bio-Technique, 3SBio and Tonghua Dongbao Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Genetic Engineering Drug market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Monoclonal Antibody
Recombinant Human Erythropoietin
Recombinant Human Interferon
Recombinant Human Growth Hormone
Recombinant Human Insulin

Segmentation by application
Medicine
Research
Industrial
Agriculture
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Shanghai Lansheng Guojian Pharmaceutical
Biotech Pharmaceutical
Anhui Anke Biotechnology
GeneScience Pharmaceuticals
Beijing SL Pharmaceutical
Jiangsu Sihuan Bioengineering
Shenzhen Neptunus Interlong Bio-Technique
3SBio
Tonghua Dongbao Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Genetic Engineering Drug market?

What factors are driving Genetic Engineering Drug market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Genetic Engineering Drug market opportunities vary by end market size?

How does Genetic Engineering Drug break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.